CIM LLC’s DexCom DXCM Stock Holding History

CIM LLC’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,512	Closed	-$705K	–	167
2024 Q3	$705K	Sell	10,512 -66	-0.6%	-$5.42K	0.1%	106
2024 Q2	$730K	Buy	10,578 +432	+4%	+$54.6K	0.11%	100
2024 Q1	$1.41M	Sell	10,146 -50	-0.5%	-$6.29K	0.21%	75
2023 Q4	$1.2M	Buy	+10,196	New	+$1.04M	0.19%	81

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CIM LLC's DXCM Position: Q4 2024 in Review

CIM LLC sold out of DexCom (DXCM) in Q4 2024, closing a stake of 10,512 shares — an estimated $705K sold.

CIM LLC first reported a position in DXCM in Q4 2023 and held it in 4 quarters. The position peaked at $1.41M in Q1 2024. 951 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

CIM LLC reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
CIM LLC sold 10,512 DexCom shares in Q4 2024, an estimated $705K.
CIM LLC first reported a position in DexCom in Q4 2023 and held it in 4 quarters.
CIM LLC's DexCom position peaked at $1.41M in Q1 2024.
951 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on CIM LLC's 13F filing for Q4 2024, filed 3 Mar 2025.